黄芪注射液联合血塞通注射液对冠心病患者心功能的影响

陈苗利1，毕立杰2 , 3

（1.陕西中医药大学第二附属医院，陕西 咸阳，712000；2. 陕西正和医院，陕西 西安，710054； 3. 空军军医大学，陕西 西安，710032）

浏览次数：263次 下载次数：334次

摘要：

目的 探讨黄芪注射液联合血塞通注射液对冠心病患者心功能的影响。方法 选择我科收治的90例冠心病患者，随机分为试验组及对照组，各45例。两组患者均给予西药常规治疗，观察组在此基础上加用静脉滴注黄芪注射液联合血塞通注 射液。比较两组患者治疗前、后左室舒张末期容积（EDV）、左室收缩末期容积（ESV）、左室射血分数（LVEF）及治疗效果。结果 治疗前，两组患者的EDV、ESV、LVEF比较，差异无统计学意义（P>0.05）；治疗后，两组间患者的EDV、ESV 和LVEF 均优于治疗前，且观察组优于对照组（P<0.05）。观察组患者的治疗总有效率为86.67%，明显高于对照组的68.89%（P<0.05）。结论 在常规治疗的基础上予以黄芪注射液联合血塞通注射液能明显改善冠心病患者的心功能，减少EDV、ESV 和升高LVEF，从而改善患者的预后。

关键词：黄芪注射液；血塞通注射液；冠心病；心功能

中图分类号：R277.7文献标志码：A文章编号：2096-1413(2017)27-0110-02

Effect of astragalus injection and Xuesaitong injection on cardiac function in patients with coronary heart disease
CHEN Miao-li 1, BI Li-jie 2,3
(1. the Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000; 2. Shaanxi Zhenghe Hospital, Xi``an 710054;

3. Air Force Medical University, Xi``an 710032, China)

ABSTRACT: Objective To investigate the effect of astragalus injection and Xuesaitong injection on cardiac function in patients with coronary heart disease (CHD). Methods Ninety cases of patients with CHD admitted in our department were selected and randomly divided into experimental group and control group, with 45 cases in each group. The two groups were given conventional western medicine, while the observation group added astragalus injection and Xuesaitong injection. The Left ventricular end-diastolic volume (EDV), left ventricular end - systolic volume (ESV), left ventricular ejection fraction (LVEF) before and after treatment, and therapeutic effects were compared between the two groups. Results Before treatment, there were no significant differences in EDV, ESV and LVEF between the two groups (P>0.05); after treatment, the EDV, ESV and LVEF of the two groups were superior to those before treatment, and those of the observation group were superior to the control group (P<0.05). The total effective rate of the observation group was 86.67%, which was significantly higher than 68.89% of the control group (P<0.05). Conclusion On the basis of routine treatment, astragalus injection combined with Xuesaitong injection can significantly improve cardiac function in patients with CHD, reduce EDV, ESV and increase LVEF, so as to improve the prognosis of patients.

KEYWORDS: astragalus injection; Xuesaitong injection; coronary heart disease (CHD); cardiac function

参考文献：
[1] 葛均波,徐永健.内科学[M].8 版.人民卫生出版社,2013:227.
[2] 国际心脏病学会和协会WHO 命名标准化联合专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(1):75-76.
[3] 刘革命.黄芪注射液联合丹参注射液对冠心病心力衰竭患者左室功能及重构的影响[J].中国中医急症,2009,18(11):1808.
[4] 王和银,方统念,吴帆,等.益气活血法对冠心病介入术后患者心功能的影响[J].新中医,2009,36(4):569-570.
[5] 郭雪红.黄芪注射液的药理作用及临床应用研究进展[J].中国药房,2015,26(21):3018-3021.
[6] 丰俊鹏.血塞通注射液对STEMI 患者急诊PCI 术后心脏微循环及近期心功能的影响[D].郑州:河南中医学院,2015.
[7] 匡荣仁,徐燕,原丽萍,等.三七总皂苷对急性心肌梗死急诊介入术后心肌灌注及临床预后的影响[J].中外健康文摘,2013,9(38):32-33.
[8] 骆桂侠.血塞通治疗老年性冠心病心绞痛效果评价[J].吉林医学, 2013,34(24):4938.
[9] 樊清波,李小威,简立国,等.三七总皂苷对大鼠心肌梗死后血管新生及微小RNA-21 表达的影响[J].郑州大学学报:医学版,2014,49(1):48-52.
[10] 孙东升,黄惠玲,黄慧芳.大剂量血塞通注射液对不稳定型心绞痛患者血小板聚集率的影响[J].中国中西医结合急救杂志,2011,18(2):92-93.